<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20250802066727N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2025-11-05</date_registration>
      <primary_sponsor>Shahid Beheshti University of Medical Sciences</primary_sponsor>
      <public_title>The Effect of Acupressure on Pain Severity, Anxiety, and Vital Sign in Patients with Renal Colic Referring to the Emergency Department</public_title>
      <acronym></acronym>
      <scientific_title>The Effect of Acupressure on Pain Severity, Anxiety, and Vital Sign in Patients with Renal Colic Referring to the Emergency Department</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2025-10-20</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>100</target_size>
      <recruitment_status>Recruiting</recruitment_status>
      <url>https://irct.ir/trial/86789</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: After confirming the inclusion criteria, eligible participants will be randomly assigned into two groups using simple randomization. For this purpose, each participant will be assigned a number generated by a random number table or statistical software such as SPSS. The participants’ names will be recorded in the order of their entry into the study, and the corresponding numbers will be extracted from the table. Even numbers will be assigned to the intervention group (combined acupressure and pharmacological method), and odd numbers will be assigned to the control group (routine pharmacological method).
To ensure allocation concealment, the group assignments of each participant will be placed in sealed, opaque envelopes prepared and numbered by an individual who is not a member of the research team.
The allocation ratio in this study will be 1:1.</study_design>
      <phase>3</phase>
      <hc_freetext>Acute renal colic pain in patients referred to the emergency department.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Participants in the intervention group will receive a combined intervention of acupressure and pharmacological treatment. Acupressure will be performed by a trained and qualified researcher on the Qiu point (corresponding to BL-23 in Traditional Chinese Medicine) along the bladder meridian in the lumbar region. The patient will lie on the side with the painful area on top. Acupressure will be applied using the thumb or index finger gradually, uniformly, and continuously, with a tolerable pressure. The procedure consists of three 1-minute pressure sessions with 30-second rests in between, totaling approximately 5 minutes. The researcher will monitor patient tolerance continuously, and the procedure will be stopped immediately if the patient feels discomfort or wishes to discontinue. Simultaneously, participants will receive the routine pharmacological pain relief according to the emergency department protocol. Intervention 2: Control group: Participants in the control group will receive routine emergency care including pharmacological pain relief according to the emergency department protocol, without any additional interventions such as acupressure or other non-pharmacological methods.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
The data will be shared in a coded form, ensuring the confidentiality of participants’ names and personal information.

When:
Start of access period after results publication

To whom:
Researchers affiliated with academic and scientific institutions

Conditions:
For further investigations, addressing study limitations, and use in clinical practice

Where to obtain:
Dr. Fatemeh Hasan Doost fateme_hd_66@yahoo.com

How to obtain:
After sending an email to the author, the required data will be provided while respecting intellectual property rights.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Fatemeh Hasan Doost</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Faculty of Nursing and Midwifery, Valiasr St., at the intersection with Ayatollah Hashemi Rafsanjani Highway, in front of Shahid Rajaei Heart Hospital, Tehran, Iran.</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1996835119</zip>
        <telephone>021  88655366-70</telephone>
        <email>fateme_hd_66@yahoo.com</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Fatemeh Hasan Doost</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Faculty of Nursing and Midwifery, Valiasr St., at the intersection with Ayatollah Hashemi Rafsanjani Highway, in front of Shahid Rajaei Heart Hospital, Tehran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1996835119</zip>
        <telephone>021 88655366-70</telephone>
        <email>fateme_hd_66@yahoo.com</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Definite diagnosis of renal colic by the emergency department physician
Age between 18 and 65 years
Full consciousness (Glasgow Coma Scale score = 15)
Pain intensity at the time of enrollment ranging from mild to moderate, with a score of 3 to 6 on the Visual Analogue Scale (VAS)</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>65 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Voluntary withdrawal from participation at any stage of the study
History of abdominal or genitourinary surgery
Need for emergency hospitalization or receiving specialized treatments outside the study protocol
Lack of consistent cooperation with the study instructions and requirements</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>N23</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Unspecified renal colic</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Drugs</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Participants in the intervention group will receive a combined intervention of acupressure and pharmacological treatment. Acupressure will be performed by a trained and qualified researcher on the Qiu point (corresponding to BL-23 in Traditional Chinese Medicine) along the bladder meridian in the lumbar region. The patient will lie on the side with the painful area on top. Acupressure will be applied using the thumb or index finger gradually, uniformly, and continuously, with a tolerable pressure. The procedure consists of three 1-minute pressure sessions with 30-second rests in between, totaling approximately 5 minutes. The researcher will monitor patient tolerance continuously, and the procedure will be stopped immediately if the patient feels discomfort or wishes to discontinue. Simultaneously, participants will receive the routine pharmacological pain relief according to the emergency department protocol</i_keyword>
      <i_keyword>Control group: Participants in the control group will receive routine emergency care including pharmacological pain relief according to the emergency department protocol, without any additional interventions such as acupressure or other non-pharmacological methods.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pain intensity measured by the Visual Analogue Scale (VAS). Timepoint: before the intervention, 15 minutes, and 30 minutes after the intervention. Method of measurement: Visual Analogue Scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Anxiety level measured by the Spielberger State-Trait Anxiety Inventory (STAI-S). Timepoint: before the intervention, 15 minutes, and 30 minutes after the intervention. Method of measurement: Spielberger State-Trait Anxiety Inventory.</sec_outcome>
      <sec_outcome>Vital signs including pulse rate, respiratory rate, blood pressure. Timepoint: before the intervention, 15 minutes, and 30 minutes after the intervention. Method of measurement: Blood pressure will be measured using a digital sphygmomanometer, radial pulse rate will be counted manually, and respiratory rate will be recorded by observing chest movements.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shahid Beheshti University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2025-10-20</approval_date>
        <contact_name>Ethics Committee of the Faculties of Pharmacy, Nursing and Midwifery - Shahid Beheshti University of</contact_name>
        <contact_address>Faculty of Nursing and Midwifery, Valiasr St., at the intersection with Ayatollah Hashemi Rafsanjani Highway, in front of Shahid Rajaei Heart Hospital, Tehran, Iran. Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
